These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23244494)

  • 1. 3D molecular descriptors important for clinical success.
    Kombo DC; Tallapragada K; Jain R; Chewning J; Mazurov AA; Speake JD; Hauser TA; Toler S
    J Chem Inf Model; 2013 Feb; 53(2):327-42. PubMed ID: 23244494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
    Shityakov S; Neuhaus W; Dandekar T; Förster C
    Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escape from flatland: increasing saturation as an approach to improving clinical success.
    Lovering F; Bikker J; Humblet C
    J Med Chem; 2009 Nov; 52(21):6752-6. PubMed ID: 19827778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting drug promiscuity using Gaussian ensemble screening.
    Pérez-Nueno VI; Venkatraman V; Mavridis L; Ritchie DW
    J Chem Inf Model; 2012 Aug; 52(8):1948-61. PubMed ID: 22747187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular descriptors influencing melting point and their role in classification of solid drugs.
    Bergström CA; Norinder U; Luthman K; Artursson P
    J Chem Inf Comput Sci; 2003; 43(4):1177-85. PubMed ID: 12870909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug absorption based on immobilized artificial membrane (IAM) chromatography separation and calculated molecular descriptors.
    Yen TE; Agatonovic-Kustrin S; Evans AM; Nation RL; Ryand J
    J Pharm Biomed Anal; 2005 Jul; 38(3):472-8. PubMed ID: 15890485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we discover pharmacological promiscuity early in the drug discovery process?
    Peters JU; Hert J; Bissantz C; Hillebrecht A; Gerebtzoff G; Bendels S; Tillier F; Migeon J; Fischer H; Guba W; Kansy M
    Drug Discov Today; 2012 Apr; 17(7-8):325-35. PubMed ID: 22269136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do biologically relevant compounds have more chance to be drugs?
    Kong DX; Ren W; Lü W; Zhang HY
    J Chem Inf Model; 2009 Oct; 49(10):2376-81. PubMed ID: 19852515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-retention-pharmacokinetic relationship studies.
    Agatonovic-Kustrin S; Turner JV; Glass BD
    Drug Metab Lett; 2008 Apr; 2(2):130-7. PubMed ID: 19356082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological promiscuity: dependence on compound properties and target specificity in a set of recent Roche compounds.
    Peters JU; Schnider P; Mattei P; Kansy M
    ChemMedChem; 2009 Apr; 4(4):680-6. PubMed ID: 19266525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling promiscuity based on in vitro safety pharmacology profiling data.
    Azzaoui K; Hamon J; Faller B; Whitebread S; Jacoby E; Bender A; Jenkins JL; Urban L
    ChemMedChem; 2007 Jun; 2(6):874-80. PubMed ID: 17492703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculation of aqueous solubility of crystalline un-ionized organic chemicals and drugs based on structural similarity and physicochemical descriptors.
    Raevsky OA; Grigor'ev VY; Polianczyk DE; Raevskaja OE; Dearden JC
    J Chem Inf Model; 2014 Feb; 54(2):683-91. PubMed ID: 24456022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical descriptors of aromatic character and their use in drug discovery.
    Ritchie TJ; Macdonald SJ
    J Med Chem; 2014 Sep; 57(17):7206-15. PubMed ID: 24856517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the Relationship between Molecular Hit Rates in High-Throughput Screening and Molecular Descriptors.
    Hansson M; Pemberton J; Engkvist O; Feierberg I; Brive L; Jarvis P; Zander-Balderud L; Chen H
    J Biomol Screen; 2014 Jun; 19(5):727-37. PubMed ID: 23975880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.